Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Genetic abnormalities in GBM brain tumors

ABSTRACT: Examine the genetic abnormality in brain tumors

ORGANISM(S): Homo sapiens

PROVIDER: GSE24446 | GEO | 2010/11/21

SECONDARY ACCESSION(S): PRJNA133495

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Genetic abnormalities in GBM brain tumors

Project description:Examine the genetic abnormality in brain tumors Genomic DNA were extracted from frozen brain tumor samples and CGH assay were performed to compare the similarity genomic abnormality among different cell groups.

2010-11-21 | E-GEOD-24446 | biostudies-arrayexpress

Genetic abnormalities in various cell subpopulations of GBM brain tumors

Project description:GBM is a heterogenous tumor. Based on membrane protein expression, the GBM single cell dissociates were seperated into different subfractions by FACS assay. The genomic aberration among each populations were compared by analysis of CGH data. Genomic DNA were extracted from sorted cell population and CGH assay were performed to compare the similarity genomic abnormality among different cell groups.

2010-11-21 | E-GEOD-24452 | biostudies-arrayexpress

GBM brain tumors

Project description:This SuperSeries is composed of the following subset Series: GSE24446: Genetic abnormalities in GBM brain tumors GSE24452: Genetic abnormalities in various cell subpopulations of GBM brain tumors GSE24557: Exon-level expression profiles of GBM brain tumors Refer to individual Series

2010-11-21 | E-GEOD-24558 | biostudies-arrayexpress

Genetic abnormalities in various cell subpopulations of GBM brain tumors

2010-11-21 | GSE24452 | GEO

Analysis of clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome.

Project description:Primary outcome(s): Clinicopathologic characteristics, carcinogenic mechanisms and genetic abnormality in colorectal tumors with MSI including Lynch syndrome.

| 2640382 | ecrin-mdr-crc

Immunogenomics of Malignant Brain Tumors

Project description:Immunogenomics of Malignant Brain Tumors

| PRJNA763945 | ENA

Immunogenomics of Malignant Brain Tumors

Project description:Immunogenomics of Malignant Brain Tumors

| PRJNA763970 | ENA

Exon-level expression profiles of GBM brain tumors

Project description:Transcriptome analysis of RNAs from brain tumor Investigate potential of true exon level expression profiling . We analyzed brain tumor from 16 patients (9 males, 7 females) using the Affymetrix Human Exon 1.0 ST V2 platform. Array data was processed by Affymetrix Exon Array Computational Tool.

2010-11-21 | E-GEOD-24557 | biostudies-arrayexpress

Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma

Project description:This phase I trial studies the side effects and best dose of pembrolizumab and to see how well it works in treating younger patients with high-grade gliomas (brain tumors that are generally expected to be fast growing and aggressive), diffuse intrinsic pontine gliomas (brain stem tumors), brain tumors with a high number of genetic mutations, ependymoma or medulloblastoma that have come back (recurrent), progressed, or have not responded to previous treatment (refractory). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may induce changes in the body’s immune system, and may interfere with the ability of tumor cells to grow and spread.

| 2183538 | ecrin-mdr-crc

scRNA of GBM tumors

Project description:scRNA of GBM tumors

| PRJNA996138 | ENA